Pennant Net Profit Margin 2018-2025 | PNTG

Pennant net profit margin from 2018 to 2025. Net profit margin can be defined as net Income as a portion of total sales revenue.
Pennant Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2025-06-30 $0.80B $0.03B 3.38%
2025-03-31 $0.75B $0.03B 3.47%
2024-12-31 $0.70B $0.02B 3.30%
2024-09-30 $0.65B $0.02B 3.22%
2024-06-30 $0.61B $0.02B 3.10%
2024-03-31 $0.58B $0.02B 2.78%
2023-12-31 $0.54B $0.01B 2.39%
2023-09-30 $0.52B $0.01B 2.29%
2023-06-30 $0.50B $0.01B 2.59%
2023-03-31 $0.49B $0.01B 1.44%
2022-12-31 $0.47B $0.01B 1.27%
2022-09-30 $0.46B $0.00B 0.22%
2022-06-30 $0.45B $0.00B -0.66%
2022-03-31 $0.45B $0.00B 0.67%
2021-12-31 $0.44B $0.00B 0.68%
2021-09-30 $0.44B $0.01B 2.06%
2021-06-30 $0.42B $0.01B 2.84%
2021-03-31 $0.41B $0.01B 3.21%
2020-12-31 $0.39B $0.02B 3.84%
2020-09-30 $0.37B $0.01B 1.88%
2020-06-30 $0.36B $0.01B 1.38%
2020-03-31 $0.35B $0.00B 1.14%
2019-12-31 $0.34B $0.00B 0.59%
2019-06-30 $0.23B $0.01B 3.42%
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.839B $0.695B
The Pennant Group Inc. through subsidiaries offers home health, hospice and senior living services. It operates primarily in Arizona, California, Colorado, Idaho, Iowa, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin and Wyoming. The Pennant Group Inc. is based in Eagle, United States.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $20.168B 19.27
Encompass Health (EHC) United States $12.282B 24.53
DaVita (DVA) United States $9.916B 14.18
Elanco Animal Health (ELAN) United States $8.893B 19.89
Chemed (CHE) United States $6.503B 21.78
RadNet (RDNT) United States $5.428B 196.03
Option Care Health (OPCH) United States $4.531B 19.39
Addus HomeCare (ADUS) United States $2.101B 22.65
LifeStance Health (LFST) United States $2.100B 0.00
Astrana Health (ASTH) United States $1.698B 59.39
Aveanna Healthcare Holdings (AVAH) United States $1.602B 29.50
U.S Physical Therapy (USPH) United States $1.277B 31.95
Atai Life Sciences (ATAI) Germany $1.035B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.054B 0.00
Daxor (DXR) United States $0.052B 0.00
Psychemedics (PMD) United States $0.000B 0.00